2022
DOI: 10.1038/s41392-022-01137-1
|View full text |Cite
|
Sign up to set email alerts
|

Cross-neutralization and cross-protection among SARS-CoV-2 viruses bearing different variant spikes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
16
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
2

Relationship

3
3

Authors

Journals

citations
Cited by 9 publications
(16 citation statements)
references
References 8 publications
0
16
0
Order By: Relevance
“…Although not investigated due to the absence of metadata, differences between human study populations (such as age, co-morbidities and disease severity) as well as the timing of serum collection will affect titer magnitude. For example, in the Galveston dataset, hamster sera were taken at days 14, 28, and 45 post infection, and homologous titers increased ∼2.32-fold between day 14 and 45 ( 9 ). As we find that the rank order of fold change is similar between different animal model sera, the higher titers in non-human sera are not necessarily disadvantageous, as they may allow the characterisation of antigenically diverse variants without reactivity falling below the limit of detection of the assay.…”
Section: Discussionmentioning
confidence: 99%
“…Although not investigated due to the absence of metadata, differences between human study populations (such as age, co-morbidities and disease severity) as well as the timing of serum collection will affect titer magnitude. For example, in the Galveston dataset, hamster sera were taken at days 14, 28, and 45 post infection, and homologous titers increased ∼2.32-fold between day 14 and 45 ( 9 ). As we find that the rank order of fold change is similar between different animal model sera, the higher titers in non-human sera are not necessarily disadvantageous, as they may allow the characterisation of antigenically diverse variants without reactivity falling below the limit of detection of the assay.…”
Section: Discussionmentioning
confidence: 99%
“…S1A) were used for a fluorescent focus reduction neutralization test (FFRNT). The FFRNT assay has been proven reliable for high-throughput neutralization measurement [ 28 , 29 ].…”
Section: Resultsmentioning
confidence: 99%
“…A systematic analysis of the anti-genic relationship among variants provides the scientific basis for future vaccine design. We previously showed distinct cross-neutralization and protection among Alpha, Beta, Gamma, Delta, Epsilon, and Omicron BA.1 variants [ 28 ]. The current study extends the cross-neutralization analysis to the recently emerged Omicron sublineages, including BA.1, BA.2, BA.2.12.1, BA.4.6, and BA.5.…”
Section: Discussionmentioning
confidence: 99%
“…S1 ) were used for a fluorescent focus reduction neutralization test (FFRNT). The FFRNT assay has been proven reliable for high-throughput neutralization measurement (Liu et al, 2022c; Zou et al, 2022a).…”
Section: Resultsmentioning
confidence: 99%
“…A systematic analysis of the antigenic relationship among variants provides the scientific basis for future vaccine design. We previously showed distinct cross-neutralization and protection among Alpha, Beta, Gamma, Delta, Epsilon, and Omicron BA.1 variants (Liu et al, 2022c). The current study extends the cross-neutralization analysis to the recently emerged Omicron sublineages, including BA.1, BA.2, BA.2.12.1, BA.4.6, and BA.5.…”
Section: Discussionmentioning
confidence: 96%